Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2022

View Archived Issues

Novel Fanconi anemia xenograft murine model to test immunotherapy

Allorion Therapeutics presents TYK2 inhibitor ARTS-011 for the treatment of inflammatory disease

Autoantibody-induced murine dry eye disease model mimics human disease

Novel Nr1h3-/- mouse model exhibits AMD-like pathology

MFAP4 as a novel target in choroidal neovascularization

Across body parts, "parts list" gives insights into the lives of a cell

Chinese investigators patent new HIF inhibitors

Medivir and Rheos Medicines divulge new MALT1 inhibitors

U.S. researchers describe new PROTACs for cancer

Johns Hopkins University synthesizes MAP3K12/13 inhibitors

Chinese researchers disclose new CDK9 inhibitors

Kymera presents preclinical data on STAT3 degrader KTX-115

VERVE-101 shows durable editing of PCSK9 gene; GalNAc-LNPs improve delivery of base editors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...